Viewing Study NCT04582604


Ignite Creation Date: 2025-12-24 @ 7:59 PM
Ignite Modification Date: 2026-01-03 @ 10:47 AM
Study NCT ID: NCT04582604
Status: UNKNOWN
Last Update Posted: 2020-10-20
First Post: 2020-10-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ruxolitinib and Decitabine for High Risk Hematological Malignancies
Sponsor: Chinese PLA General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module